Does brachytherapy have a role in the treatment of prostate cancer?

Hematology/Oncology Clinics of North America

Volumn 10, Issue 3, 1996, Pages 653-673

  Grimm, P D ^a   Blasko, J C ^a   Ragde, H ^a   Sylvester, J ^a   Clarke, D ^a  

^a Northwest Neuroscience Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; REVIEW; TREATMENT OUTCOME;

EID: 0029973126     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70359-2     Document Type: Article

References (66)

1. R. Abadir G. Ross S. Weinstein Carcinoma of the prostate irradiated by combined I-125 and external irradiation, analysis of failure and significance of positive biopsy one year or more after therapy Int J Radiat Oncol Biol Phys 9 1983 305 309
2. J.C. Blasko P.D. Grimm H. Ragde Brachytherapy and organ preservation in the management of carcinoma of the prostate Semin Radiat Oncol 3 1993 240 249
3. J. Blasko H. Ragde P. Grimm Transperineal ultrasound of the implantation of the prostate: Morbidity and complications Scand J Urol Nephrol 137 suppl 1991 113 118
4. J. Blasko K. Wallner P. Grimm H. Ragde Prostate specific antigen based disease control following ultrasound guided I-125 iodine implantation for stage T1/T2 prostatic carcinoma J Urol 154 1995 1096 1099
5. Blasko J, Grimm P, Ragde H: 6 and 7 year results of permanent seed implantation. In Abstracts and Proceedings, Transperineal the Mainstream 6th Annual Symposium. Seattle, June 23, 1995
6. Beyer DC, Priestley JB: Biochemical disease free survival following I-125 prostate implantation. In Programs and Abstracts, ASTRO meeting Miami Beach, Oct. 1995
7. P. Bosch K. Forbes S. Parassvinichai Preliminary observations on the results of combined temporary 192 iridium implantation and external beam irradiation for carcinoma of the prostate J Urol 135 1986 722 725
8. W.J. Catalona D.S. Smith 5 year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer J Urol 152 1994 1837 1842
9. B. Corn G. Hanks T. Schultheiss Conformal treatment of prostate cancer with improved targeting: Superior prostate specific antigen response compared to standard treatment Int J Radiat Oncol Biol Phys 32 1995 325 330
10. J. Crook S. Robertson B. Esche proliferative cell nuclear antigen in post radiation biopsies Int J Radiat Oncol Biol Phys 30 1994 303 308
11. J. Crook S. Robertson G. Collin Clinical relevance of transrectal ultrasound biopsy, and serum prostate specific antigen following external beam radiotherapy for carcinoma of the prostate Int J Radiat Oncol Biol Phys 27 1993 31 37
12. Dattoli MJ, Wasserman MS, Kovall J, et al: In Programs and Abstracts, ASTRO meeting, Miami Beach, Oct 1995
13. T. DeLaney W. Shipley M. O'Leary Preoperative irradiation, lymphadenectomy and I-125 iodine implantation for patients with localized carcinoma of the prostate Int J Radiat Oncol Biol Phys 12 1986 1779 1785
14. B. Donnely J. Pedersen A. Porter Iridium 192 brachytherapy in the treatment of cancer of the prostate Clin Urol 18 1991 487
15. T. Dugan W. Shipley R. Young Biopsy after external beam radiation therapy for adenocarcinoma of the prostate: Correlation with original histological grade and current prostate specific antigen levels J Urol 146 1991 1315 1316
16. J. Forman R. Kumar G. Haas Neoadjuvant hormonal downsizing of localized carcinoma of the prostate: Effects on the volume of normal tissue Cancer Invest 13 1995 8 15
17. Z. Fuks The effect of local control on metastatic carcinoma of the prostate B. Hilaris D. Nori Proceedings of the Memorial Sloan-Kettering Cancer Center Course on Brachtherapy 1986 Memorial Sloan-Kettering New York 67 77
18. P.D. Grimm J.C. Blasko H. Ragde Ultrasound guided transperineal implantation of iodine 125 and palladium 103 for the treatment of early stage prostate cancer Atlas Urol Clin North Am 2 1994 113 125
19. G. Hanks J. Diamond J. Kraft A ten year follow up of 682 patients treated for prostate cancer with radiation therapy in the United States In J Radiat Oncol Biol Phys 13 1987 499 505
20. J. Kabalin K. Hodge J. McNeal T. Stamey Identification of residual cancer in prostate following radiation therapy. Role of transrectal ultrasound guided biopsy and prostatic specific antigen J Urol 142 1989 326 331
21. I.D. Kaplan R.S. Cox M.A. Bagshaw Prostatic specific antigen after external beam radiotherapy for prostate cancer: Follow-up J Urol 149 1993 519 522
22. K. Kaye D. Olson J.T. Payne Detailed preliminary analysis of 125 iodine implantation for localized prostate cancer using percutaneous approach J Urol 153 1995 1020 1025
23. C. Koprowski K. Berkenstock A. Borofski External beam irradiation versus iodine 125 implant in the definitive treatment of prostate cancer Int J Radiat Oncol Biol Phys 21 1991 955 960
24. D. Kuban A. El-Mahdi P. Schellhammer The significance of post irradiation prostate biopsy with long term follow-up Int J Radiat Oncol Biol Phys 24 1992 409 414
25. D. Kuban A. El-Mahdi P. Schellhammer Prostate specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer Int J Radiat Oncol Biol Phys 32 1995 307 316
26. P. Lange C. Ercole D. Lightner The value of serum prostate specific antigen determinations before and after radical prostatectomy J Urol 141 1989 873 879
27. G. Leach J. Cooper A. Kagan Radiotherapy for prostatic carcinoma: Post irradiation prostatic biopsy and recurrence patterns with long term follow-up J Urol 128 1982 505 509
28. C. Ling Permanent implants using Au-198, Pd 103 and I-125: Radiobiological considerations based on the linear quadratic model Int J Radiat Oncol Biol Phys 23 1992 81 87
29. C. Ling W.X. Li L.L. Anderson The relative biological effectiveness of I-125 and Pd 103 Int J Radiat Oncol Biol Phys 32 1995 373 378
30. D. Marinelli A. Shanberg L. Tansey Follow up biopsy in patients with carcinoma of the prostate treated by 192 iridium template irradiation plus supplemental external beam radiation J Urol 147 1992 922 925
31. A. Martinez R. Benson G. Edmundsen Pelvic lymphadenectomy combined with transperineal interstitial implantation of iridium 192 and external beam radiotherapy for locally advanced prostatic carcinoma:Technical description Int J Radiat Oncol Biol Phys 11 1985 841 847
32. A. Martinez G. Edmundsen R. Cox Combination of external beam irradiation and multiple site perineal applicator (MUPIT) for the treatment of locally advanced or recurrent prostatic, anorectal, and gynecological malignancies Int J Radiat Oncol Biol Phys 11 1985 391 398
33. T. Mate G. Kovacs A. Martinez High dose rate brachytherapy of the prostate N. Suhir High Dose Rate Brachytherapy: A Textbook 1994 Futura Armonk, NY 355 371
34. C.J. Mettlin G.P. Murphy A.S. McGinnis H.R. Menck The National Date Base Report on Prostate Cancer Cancer 76 1995 1104 1112
35. J. Morton R. Peschel Iodine-125 implants versus external beam therapy for stages A2, B, and C prostate cancer Int J Radiat Oncol Biol Phys 14 1988 1153 1157
36. J. Oesterling D. Chan J. Epstein Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy J Urol 139 1988 766 772
37. A.W. Partin C.R. Pound J.I. Clemens P.C. Walsh Serum PSA after radical prostatectomy The John Hopkins experience after 10 years Urol Clin North Am 20 1993 713
38. A. Partin J. Yoo B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110 114
39. D.F. Paulson Impact of radical prostatectomy in the management of clinically localized disease J Urol 152 1994 1826 1830
40. C. Perez L. Ackerman I. Silber Radiation therapy in the treatment of localized carcinoma of the prostate Cancer 34 1974 1059 1068
41. T.M. Pisansky S. Cha J.D. Earle Prostate specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer J Clin Oncol 11 1993 2158 2166
42. A. Pollack G. Zagars S. Kopplin Radiotherapy and androgen ablation for clinically localized high risk prostate cancer Int J Radiat Oncol Biol Phys 32 1995 13 20
43. Porter AT: Remote after loading in the interstitial radiation therapy of cancer of the prostate. In Programs and Abstracts, UCSF Symposium, San Francisco, 1988, pp 235-239
44. Prestige BR, Blasko JC, Grimm PD, et al: Post-treatment biopsy results following interstitial brachytherapy in early stage prostate cancer. In Programs and Abstracts, ASTRO Meeting, Miami Beach, Oct. 1995
45. J.B. Priestly D.C. Beyer Guided brachytherapy for treatment of confined prostate cancer Urology 40 1992 27 32
46. A. Puthwala A. Syed L. Tansey Temporary iridium implant in the management of carcinoma of the prostate Endocurietherapy Hyperthermia Oncology 1 1985 25 33
47. Ragde H, Blasko J, Grimm PD: Complications of permanent seed implantation. In Transperineal Brachytherapy-Into the Mainstream, Annual Symposium.Seatle, June 23, 1995
48. M.D. Ritter E.A. Messing T. Shanahan Prostatic specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer J Clin Oncol 10 1992 1208 1217
49. K.J. Russell C. Dunatov M.D. Haferman Prostate specific antigen in the management of patients with localized adenocarcinoma of the prostate treated with primary radiation therapy J Urol 146 1991 1046
50. P. Scardino J. Frankel T. Wheeler The prognostic significance of post irradiation biopsy results in patients with prostatic cancer J Urol 135 1986 510 516
51. P. Schellhammer L. Ladaga A. El-Mahdi Histologic characteristics of prostatic biopsies after iodine 125 implantation J Urol 123 1980 700 705
52. T. Stamey Yang H, Hay A, et al: Prostate specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909 916
53. A. Stein J. deKernion F. Dorey Prostatic specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer J Urol 147 1992 942 946
54. N. Stone R. Stock Brachytherapy for prostate cancer: Real time three dimensional interactive seed implantation Techniques in Urology 1 1995 72 80
55. J. Stromberg A. Martinez J. Gonzalez Ultrasound guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial Int J Radiat Oncol Biol Phys 33 1995 161 171
56. J.G. Trapasso J.B. DeKernion R. Smith The incidence and significance of serum prostate specific antigen after radical prostatectomy J Urol 152 1994 1821 1825
57. Wallner K, Roy J, Harrison L: Tumor control and morbidity following transperineal I-125 implantation for stage T1/T2 prostatic carcinoma. Submitted for publication
58. Wallner K, Lee H, Dattoli M: Low risk of urinary incontinence following prostate brachytherapy in patients with a prior TURP. Submitted for publication.
59. K. Wallner Short term freedom from disease progression after I-125 prostate implantation Int J Radiat Oncol Biol Phys 30 1994 405 409
60. P. Wingo T. Tong S. Bolden Cancer statistics CA Cancer J Clin 45 1995 12
61. G.K. Zagars Prostate specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapy Int J Radiat Oncol Biol Phys 23 1992 47 53
62. G.K. Zagars V.S. Kavadi Prostatic doubling time and disease relapse after radiotherapy for prostate cancer Cancer 74 1994 670 680
63. G.K. Zagars M.D. Pollack V.S. Kavadi A. von Eschenbach Prostate specific antigen and radiation therapy for clinically localized prostate cancer Int J Radiat Oncol Biol Phys 32 1995 293 306
64. A.L. Zietman J.J. Coen W.U. Shipley C.G. Willett Radical radiation therapy in the management of prostate adenocarcinoma: The initial prostatic specific antigen value as a predictor of treatment outcome J Urol 151 1994 640 645
65. A.L. Zietman W.U. Shipley J.J. Coen Radical prostatectomy and radical radiation therapy for clinical stages T1-2 adenocarcinoma of the prostate: New insights into outcome from repeat biopsy and prostatic specific antigen follow-up J Urol 152 1994 1806 1812
66. A.L. Zietman J.J. Coen K. Dallow W. Shipley The treatment of prostate cancer by conventional radiation therapy: An analysis of long term outcome Int J Radiat Oncol Biol Phys 32 1995 287 292